CIBuS: Direct Measurement of Food Intake Behaviour in Obese Women Before and After Bariatric Surgery or Lifestyle Intervention

Sponsor
Rijnstate Hospital (Other)
Overall Status
Recruiting
CT.gov ID
NCT04990947
Collaborator
(none)
24
1
32.8
0.7

Study Details

Study Description

Brief Summary

To assess changes in food intake and food preference (e.g., fat and sugar) after bariatric surgery and lifestyle intervention alone with a direct measurement.

Condition or Disease Intervention/Treatment Phase
  • Other: lifestyle / RYGB

Study Design

Study Type:
Observational
Anticipated Enrollment :
24 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Direct Measurement of Food Intake Behaviour in Obese Women Before and After Bariatric Surgery or Lifestyle Intervention
Actual Study Start Date :
Apr 7, 2021
Anticipated Primary Completion Date :
Dec 31, 2023
Anticipated Study Completion Date :
Dec 31, 2023

Arms and Interventions

Arm Intervention/Treatment
Bariatric surgery (Roux-en-Y Gastric Bypass)

Patients who are eligible for RYGB

Other: lifestyle / RYGB
No intervention, just 2 different groups will be included

Lifestyle group

Patients with a BMI > 30 who will start a lifestyle program

Other: lifestyle / RYGB
No intervention, just 2 different groups will be included

Outcome Measures

Primary Outcome Measures

  1. Changes in caloric intake [Before RYGB / lifestyle compared to 4 weeks, 3 months, 6 months and 12 months after RYGB / lifestyle]

    kcal consumed

Secondary Outcome Measures

  1. Weight / BMI [baseline, 4weeks, 3 months, 6 months, 12 months]

    weight and height measurements

  2. Drinking microstructure over time [baseline, 4weeks, 3 months, 6 months, 12 months]

    Measured with the drinkometer

  3. Change in self-reported hunger, thirst, fullness, preference [baseline, 4weeks, 3 months, 6 months, 12 months]

    VAS scale 0-100

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 67 Years
Sexes Eligible for Study:
Female
Inclusion Criteria:
  • Woman

  • Age between 18 and 67 years of age (standard for eligibility for bariatric surgery)

  • Patients must be able to adhere to the study visit schedule

  • Independently mobile

  • Patients must be able to give informed consent (IC) prior to any study procedures

  • Surgical (1) and non-surgical (2) groups:

  1. Eligible for bariatric surgery (BMI > 35 kg/m2 and clinically indicated bariatric surgery operation in agreement with the IFSO criteria)

  2. Patients with a BMI of 30-40 kg/m2, who are planning to join the COOL-lifestyle program

Exclusion Criteria:
  • Pre-operatively/lifestyle group: Factors impairing ability to consume meal such as: Significant dysphagia; Gastric outlet obstruction; Anything factor that prevents subjects from drinking or eating a meal

  • Post-operatively: Factors impairing ability to consume meal such as: Significant and persistent surgical complications or anything that prevents subjects from drinking or eating a meal.

  • Systemic or gastrointestinal condition which may affect food intake or preference (including diabetes mellitus)

  • Pregnancy or lactation, or planning to get pregnant during the study period

  • Patients who have an intolerance or allergy for one of the components of the test product (e.g. lactose)

  • Active and significant psychiatric illness including substance misuse

  • Significant cognitive or communication issues

  • Medications with documented effect on food intake or food preference

  • Participating in another scientific study at the same time, if

Contacts and Locations

Locations

Site City State Country Postal Code
1 Yonta van der Burgh Arnhem Netherlands 6815 AD

Sponsors and Collaborators

  • Rijnstate Hospital

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Rijnstate Hospital
ClinicalTrials.gov Identifier:
NCT04990947
Other Study ID Numbers:
  • 2020-1594
First Posted:
Aug 5, 2021
Last Update Posted:
Aug 5, 2021
Last Verified:
Feb 1, 2021
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No

Study Results

No Results Posted as of Aug 5, 2021